Pharmaterials Ltd The Queen's Awards for Enterprise 2008
Home
Company Locations
Careers
Initiate a Project
Contact Us
Request A Brochure
Search Our Site
Home | COMPANY    |     POLYMORPHS/SALTS/CO-CRYSTALS    |     FORMULATION DEVELOPMENT    |     CONSULTANCY    |     GMP MANUFACTURE    |     PHYS PROPS    |     INHALATION SERVICES    |    
Formulation Development
Preclinical Formulation Clinical Formulation Solid Oral Dosage Amorphous Solid Dispersions MacroSOLV Formulation Screening Inhaled / Respiratory Drug Delivery: Inhalation product development First time in human fast Analytical Development Excipient compatibility testing Drug Delivery Licensing Quality by Design in Formulation Development

Drug Delivery Licensing Opportunities.

Inhaled drug delivery

Pharmaterials Respisolv® technology is a novel patented means of delivery of small and macromolecular drugs to the lung (or nasal delivery) using pressurised metered dose inhaler (pMDI) technology.  This technology is suitable for local delivery or systemic delivery.

Please contact us for more details of our licensing opportunities.

  Home  |  Company  |  Polymorphs/Salts/Co-crystals  |  Formulation Development  |  Consultancy  |  GMP manufacture  |  Phys Props  |  Inhalation services  |  News  |  Site Map
© 2009 Pharmaterials Ltd, All rights reserved.       Site by : UKWebCo.com